Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mattea Reinisch

11PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Nov 03, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.

Monika Graeser, Oleg Gluz, Peter Schmid

|Mar 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.

Niklas Gremke, Isabelle Besong, Alina Stroh

|Sep 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.

Theresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt

|Apr 14, 2023
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.

Mattea Reinisch, Simona Bruzas, Oleg Gluz

|Apr 07, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.

Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss

|Mar 30, 2022
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.

Simona Bruzas, Oleg Gluz, Nadia Harbeck

Pageof 2

Frequent Collaborators

6 joint publications

Sherko Kümmel

3 joint publications

Jens-Uwe Blohmer

2 joint publications

Elisabeth Breit

2 joint publications

Christian Jackisch

2 joint publications

Carsten Denkert

2 joint publications

Sibylle Loibl

2 joint publications

Peter A Fasching

2 joint publications

Nadia Harbeck

2 joint publications

Marc Thill

2 joint publications

Marion van Mackelenbergh

Frequent Collaborators

6 joint publications

Sherko Kümmel

3 joint publications

Jens-Uwe Blohmer

2 joint publications

Elisabeth Breit

2 joint publications

Christian Jackisch

Top Related Videos

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

2.1K
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

1.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

299
See more related videos

Top Related Videos

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

2.1K
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

1.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

299
See more related videos